A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experience.
Alvir
J M
JM
Lieberman
J A
JA
D000380:Agranulocytosis / Q000139:chemically induced* / Q000517:prevention & control*; D003024:Clozapine / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D007958:Leukocyte Count / Q000191:economics; D012307:Risk Factors; D014481:United States
D003024:Clozapine